Dimensional Fund Advisors
BIOA

Dimensional Fund Advisors’s BioAge Labs BIOA Stock Holding History

Dimensional Fund Advisors’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.66M Buy
394,138
+179,592
+84% +$3.24M ﹤0.01% 2316
2026
Q1 		$3.75M Buy
+214,546
New +$4.13M ﹤0.01% 2577

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Dimensional Fund Advisors's BIOA Position: Q2 2026 in Review

Dimensional Fund Advisors increased its BioAge Labs (BIOA) stake by 84% in Q2 2026, buying an estimated $3.24M and bringing the position to 394,138 shares worth $9.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2316.

Dimensional Fund Advisors first reported a position in BIOA in Q1 2026 and has held it in 2 quarters since. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Dimensional Fund Advisors held 394,138 shares of BioAge Labs worth $9.66M as of Q2 2026.
  • Dimensional Fund Advisors bought 179,592 BioAge Labs shares in Q2 2026, an estimated $3.24M.
  • BioAge Labs made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2316 holding.
  • Dimensional Fund Advisors first reported a position in BioAge Labs in Q1 2026 and has held it in 2 quarters since.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.